Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEPHROS INCNEPH · Entity 7279 | Director | December 16, 2019 | December 18, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEPHROS INC
Report date December 16, 2019 · Filed December 18, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,448 |
Reported balance
After 2019-12-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-12-16 · Grant · Acquired 3,448 · Balance 3,448 F1: On December 16, 2019, the Company granted 3,448 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Mieyal in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.57 · Expires 2029-12-16 | Direct | 5,568 |
Reported balance
After 2019-12-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-12-16 · Grant · Acquired 5,568 · Balance 5,568 F2: On December 16, 2019, the Company granted an option to purchase 5,568 shares of common stock of the Company (the "Option") in respect of the service by Mr. Mieyal as a member of the Board of Directors of the Company. The Option was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Option was granted to Wexford Capital LP. The Option vests as to 1,856 shares on each of 12/16/19, 12/16/20 and 12/16/21. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 16, 2019, the Company granted 3,448 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Mieyal in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date.
F2: On December 16, 2019, the Company granted an option to purchase 5,568 shares of common stock of the Company (the "Option") in respect of the service by Mr. Mieyal as a member of the Board of Directors of the Company. The Option was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Option was granted to Wexford Capital LP. The Option vests as to 1,856 shares on each of 12/16/19, 12/16/20 and 12/16/21.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 16, 2019 Filed Dec 18, 2019 17:09 UTC | NEPHROS INC NEPH · Entity 7279 | GrantStock Option (Right to Buy) · Derivative | 5,568 | $0.00 Strike: $8.57 | $0.00 |
DisclosureSEC source: 0000914190-19-000501 · edgar.xml · derivative · entry 2 Mieyal Paul A · CIK 0001412471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,568 Underlying: Common Stock · 5,568 shares Expires 2029-12-16 F2 · derivative.exercise_date: On December 16, 2019, the Company granted an option to purchase 5,568 shares of common stock of the Company (the "Option") in respect of the service by Mr. Mieyal as a member of the Board of Directors of the Company. The Option was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Option was granted to Wexford Capital LP. The Option vests as to 1,856 shares on each of 12/16/19, 12/16/20 and 12/16/21. F2 · ownership.direct: On December 16, 2019, the Company granted an option to purchase 5,568 shares of common stock of the Company (the "Option") in respect of the service by Mr. Mieyal as a member of the Board of Directors of the Company. The Option was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Option was granted to Wexford Capital LP. The Option vests as to 1,856 shares on each of 12/16/19, 12/16/20 and 12/16/21. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 17:09 UTC | NEPHROS INC NEPH · Entity 7279 | GrantCommon Stock | 3,448 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-19-000501 · edgar.xml · nonDerivative · entry 1 Mieyal Paul A · CIK 0001412471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,448 F1 · shares: On December 16, 2019, the Company granted 3,448 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Mieyal in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date. F1 · ownership.direct: On December 16, 2019, the Company granted 3,448 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Mieyal in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date. Read SEC document |
| December 19, 2018 Filed Dec 21, 2018 16:54 UTC | NEPHROS INC NEPH · Entity 7279 | GrantStock Option (Right to Buy) · Derivative | 46,457 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0000914190-18-000585 · edgar.xml · derivative · entry 1 Mieyal Paul A · CIK 0001412471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,457 Underlying: Common Stock · 46,457 shares Expires 2028-12-19 F1 · derivative.exercise_date: On December 19, 2018, the Company granted an option to purchase 46,457 shares of common stock of the Company (the "Option") in respect of the service by Mr. Mieyal as a member of the Board of Directors of the Company. The Option was granted under the Company's 2015 Equity Incentive Plan ("the 2015 Plan"). At the request of Mr. Mieyal, the Option was granted to Wexford Capital LP. The Option vests as to 15,486 shares on each of 12/19/18 and 12/19/19, and as to 15,485 shares on 12/19/20. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:23 UTC | NEPHROS INC NEPH · Entity 7279 | GrantCommon Stock | 47,673 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-18-000560 · edgar.xml · nonDerivative · entry 1 Mieyal Paul A · CIK 0001412471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,673 F1 · security: On December 14, 2018, the Company granted 47,673 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Mieyal in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date. F1 · shares: On December 14, 2018, the Company granted 47,673 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Mieyal in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date. F1 · ownership.direct: On December 14, 2018, the Company granted 47,673 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Mieyal in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date. Read SEC document |
| December 20, 2017 Filed Dec 22, 2017 11:36 UTC | NEPHROS INC NEPH · Entity 7279 | GrantNon-qualified stock option · Derivative | 40,284 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000914190-17-000394 · edgar.xml · derivative · entry 2 Mieyal Paul A · CIK 0001412471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,284 Underlying: Common Stock · 40,284 shares Expires 2027-12-20 F2 · derivative.exercise_date: On December 20, 2017, the Company granted an option to purchase 40,284 shares of common stock of the Company (the "Option") in respect of the service by Mr. Mieyal as a member of the Board of Directors of the Company. The Option was granted under the 2015 Plan. At the request of Mr. Mieyal, the Option was granted to Wexford Capital LP. The Option vests as to 13,428 shares on each of 12/20/17, 12/20/18 and 12/20/19. F2 · ownership.direct: On December 20, 2017, the Company granted an option to purchase 40,284 shares of common stock of the Company (the "Option") in respect of the service by Mr. Mieyal as a member of the Board of Directors of the Company. The Option was granted under the 2015 Plan. At the request of Mr. Mieyal, the Option was granted to Wexford Capital LP. The Option vests as to 13,428 shares on each of 12/20/17, 12/20/18 and 12/20/19. Read SEC document |
| December 20, 2017 Filed Dec 22, 2017 11:36 UTC | NEPHROS INC NEPH · Entity 7279 | GrantCommon Stock | 73,864 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-17-000394 · edgar.xml · nonDerivative · entry 1 Mieyal Paul A · CIK 0001412471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,864 F1 · security: On December 20, 2017, the Company granted 73,864 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Mieyal in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date. F1 · shares: On December 20, 2017, the Company granted 73,864 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Mieyal in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date. F1 · ownership.direct: On December 20, 2017, the Company granted 73,864 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Mieyal in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Mieyal, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.